EB1 Antibodies

Santa Cruz Biotechnology features a diverse variety of EB1 monoclonal antibodies for advanced research in cell biology and molecular mechanisms. EB1 Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EB1, or End Binding protein 1, plays a crucial role in microtubule dynamics and stability, acting as a plus-end tracking protein that is essential for proper cell division and intracellular transport. Its involvement in the regulation of microtubule growth makes EB1 a significant player in processes such as mitosis and cellular signaling pathways. Understanding the function of EB1 is vital for elucidating mechanisms underlying various diseases, including cancer, where microtubule dynamics are often disrupted. EB1 monoclonal antibodies enable detailed investigation of microtubule organization and dynamics in living cells. Researchers can effectively track EB1 localization and movement during different phases of the cell cycle. Advanced imaging techniques combined with EB1 monoclonal antibodies allow for real-time visualization of microtubule growth patterns. Santa Cruz Biotechnology monoclonal antibodies targeting EB1 support researchers worldwide in advancing our understanding of cellular processes and disease mechanisms.